After the passage of the Affordable Care Act legislation, the US health insurance market was shaken up by a number of new dynamics, including the growth in numbers of covered people, the introduction of health exchanges, and the new emphasis on preventive medicine. Even though the current health regulatory landscape has been in flux, the shift to value-based medicine has not changed and insurers are still looking for more ways to manage the health of their covered population, differentiate their offerings, and get new datasets, among other efforts.